Seneca Biopharma

$0.619
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0231 (-3.67%) Today
+$0.012 (+1.98%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell SNCA and other stocks, options, and ETFs commission-free!

About SNCA

Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. The listed name for SNCA is Seneca Biopharma, Inc. Common Stock.

CEO
Kenneth C. Carter
Employees
5
Headquarters
Germantown, Maryland
Founded
1996
Market Cap
10.50M
Price-Earnings Ratio
Dividend Yield
Average Volume
181.81K
High Today
$0.631
Low Today
$0.5885
Open Price
$0.63
Volume
306.99K
52 Week High
$4.09
52 Week Low
$0.50

Collections

SNCA Earnings

-$1.45
-$0.97
-$0.48
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 25, Pre-Market

You May Also Like